Erenumab (AMG334) An Antagonist to Canonical CGRP-Receptor Does Not Impair vasodilatory or Contractile Responses to Other Agents In Human Isolated Cerebral Arteries

被引：0

|

作者：

Ohlsson, Lena ^{[1
]}

Kronvall, Erik ^{[2
,3
]}

Xu, Cen ^{[4
]}

Snellman, Josefin ^{[5
]}

Edvinsson, Lars ^{[1
]}

机构：

[1] Dept Internal Med, Lund, Sweden

[2] Lund Univ Hosp, Dept Internal Med, Lund, Sweden

[3] Lund Univ Hosp, Dept Neurosurg, Lund, Sweden

[4] Amgen Inc, Newbury Pk, CA USA

[5] Novartis Pharma AG, Basel, Switzerland

来源：

NEUROLOGY | 2019年 / 92卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S17.002

引用

收藏

页数：2

相关论文

共 4 条

[1] ERENUMAB (AMG334) AN ANTAGONIST TO CANONICAL CGRP-RECEPTOR DOES NOT IMPAIR VASODILATORY OR CONTRACTILE RESPONSES TO OTHER AGENTS IN HUMAN ISOLATED CEREBRAL ARTERIES
Ohlsson, L.
Kronval, E.
Xu, C.
Snellman, J.
Edvinsson, L.
CEPHALALGIA, 2018, 38 : 31 - 31
[2] Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries
Ohlsson, Lena
Haanes, Kristian A.
Kronvall, Erik
Xu, Cen
Snellman, Josefin
Edvinsson, Lars
CEPHALALGIA, 2019, 39 (14) : 1745 - 1752
[3] Erenumab (AMG 334), an antagonist of the Canonical Calcitonin Gene-Related Peptide Receptor, does not impair vasodilatory or contractile responses to other agents in human isolated cerebral arteries
Ohlsson, Lena
Haanes, Kristian A.
Kronvall, Erik
Xu, Cen
Snellman, Josefin
Edvinsson, Lars
CEPHALALGIA, 2019, 39 : 213 - 214
[4] Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries
Rubio-Beltran, Eloisa
Labastida-Ramirez, Alejandro
Haanes, Kristian A.
van den Bogaerdt, Antoon
Bogers, Ad J. J. C.
Dirven, Clemens
Danser, A. H. Jan
Xu, Cen
Snellman, Josefin
MaassenVanDenBrink, Antoinette
CEPHALALGIA, 2019, 39 (14) : 1735 - 1744